Latest News for: P bcl

Edit

SHIFTING OF THE REGISTERED OFFICE OF THE COMPANY WITHIN THE LOCAL LIMITS OF CITY OF DELHI (BCL Enterprises Ltd)

Public Technologies 27 Nov 2025
) To,. The Metropolitan Stock Exchange of India Limited 205(A), 2nd floor, Piramal Agastya Corporate Park, Kamani Junction, ... BCL. To, ... 539621. Sub ... Thanking you, Yours faithfully, For BCL Enterprises Limited ... BCL Enterprises Limited. CIN ... BCL Enterprises Ltd.
Edit

Newspaper Publication of the Un-Audited Financial Results for the Quarter and half year ended September 30, 2025 (BCL Enterprises Ltd)

Public Technologies 15 Nov 2025
). The text version of this document is not available ... BCL Enterprises Ltd.
Edit

Outcome of the Board Meeting of held on 14th November, 2025 (BCL Enterprises Ltd)

Public Technologies 14 Nov 2025
). The text version of this document is not available ... BCL Enterprises Ltd.
Edit

Intimation pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure requirements) Regulation, 2015. (BCL Enterprises Ltd)

Public Technologies 13 Nov 2025
) Company Name (SYMBOL) BCL Enterprises Limited ( BCL ) ... and concluded at 07.00 P.M ... Attachment 13112025_BCL_01.pdf. Attachments Original document Permalink. Disclaimer. BCL Enterprises Ltd.
Edit

BCL Industries Q2 Results: Revenue slips 4% YoY to ₹720 crore; net profit flat at ...

Live Mint 12 Nov 2025
BCL Industries reported Q2FY26 revenue of ₹720 crore, ...
Edit

Ascentage Pharma to Present Data from Two Clinical Studies for Bcl-2 Inhibitor Lisaftoclax,

The Eagle-Tribune 04 Nov 2025
ROCKVILLE, Md. and SUZHOU, China, Nov ... (NASDAQ.
Edit

Ascentage Pharma to Present Data from Two Clinical Studies for Bcl-2 Inhibitor Lisaftoclax, Including an ...

Nasdaq Globe Newswire 04 Nov 2025
ROCKVILLE, Md. and SUZHOU, China, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International Inc. (NASDAQ. AAPG; HKEX ... .
Edit

Ascentage Pharma to Present Data from Two Clinical Studies for Bcl-2 Inhibitor Lisaftoclax, Including an Oral Report, at ASH 2025 (Form 6-K) (Ascentage Pharma Group International)

Public Technologies 04 Nov 2025
Ascentage Pharma to Present Data from Two Clinical Studies for Bcl-2 Inhibitor Lisaftoclax, Including an Oral Report, at ASH 2025 ... Developed by Ascentage Pharma, lisaftoclax is an orally available Bcl-2 inhibitor.
Edit

Reconciliation of Share Capital Audit Report under Regulation 76 of SEBI (Depositories and Participants) Regulations, 2018 (BCL Enterprises Ltd)

Public Technologies 24 Oct 2025
). Date. 24th October, 2025. To, ... BCL. To,. The BSE Limited ... 539621 ... For BCL Enterprises Limited ... 510, Arunachal Building, 19, Barakhamba Road, New D elhi-110001 BCL Enterprises Limited ... BCL Enterprises Limited Registered Office Address ... ... ... BCL Enterprises Ltd.
Edit

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended on 30th September, 2025. (BCL Enterprises Ltd)

Public Technologies 08 Oct 2025
BCL ... MAS Services Limited, the Registrar and Share Transfer Agent (RTA) of BCL Enterprises Limited ("the Company") for the Quarter ended as on 30th September, 2025 ... Thanking you For BCL Enterprises Limited ... BCL Enterprises Limited.
Edit

Submission of Scrutinizer Report and Voting Results of 40th Annual General Meeting of BCL Enterprises Limited (“the Company”) (BCL Enterprises Ltd)

Public Technologies 03 Oct 2025
BCL ... Submission of Scrutinizer Report and Voting Results of 40thAnnual General Meeting of BCL Enterprises Limited (“the Company”) ... For BCL ENTERPRISES LIMITED ... For BCL Enterprises Limited ... For BCL Enterprlses Llmlted ... BCL Enterprises Ltd.
Edit

Trapani Shark Kulübü Başkanı Antonini, İsrail takımlarının BCL'den çıkarılmasını istiyor

Istiklal 30 Sep 2025
Tarafsız ve güvenilir habercilik için tıklayın ....
Edit

Disclosure under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 (BCL Enterprises Ltd)

Public Technologies 30 Sep 2025
). 30thSeptember, 2025. To,. The BSE Limited. Department of Corporate Services Phiroze Jeejeebhoy Towers,. Dalal Street, Mumbai-400001 Scrip Code ... BCL ... For BCL ENTERPRISES LIMITED ... For BCL ENTERPRISES LIMITED ... For BCL ENTERPRISES LIMITED ... BCL Enterprises Ltd.
Edit

Intimation of Closure of Trading Window (BCL Enterprises Ltd)

Public Technologies 27 Sep 2025
) To,. The Listing Department. The Metropolitan Stock Exchange of India Limited, 205(A), 2nd floor, Piramal Agastya. Corporate Park, Kamani Junction, ... BCL. To, ... For and on behalf of BCL Enterprises Limited ... KUMAR ... BCL Enterprises Limited ... BCL Enterprises Ltd.
Edit

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 – Demise of an Independent Director (BCL Enterprises Ltd)

Public Technologies 16 Sep 2025
). Date. 16thSeptember, 2025. To,. The Listing Department. The Metropolitan Stock Exchange of India Limited, ... LBS Road, Kurla (West), Mumbai- 400070. MSEI Symbol. BCL ... 539621 ... Sub ... Mr ... For BCL Enterprises Limited ... For BCL ENTERPRISES LIMITED ... BCL Enterprises Ltd.

Article Search

tools
×
×
×
×